Indivior Pharmaceuticals (INDV) Cash & Current Investments (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Cash & Current Investments of $175.0 million for Q1 2026, down 53.08% year-over-year from $373.0 million in Q1 2025, and down 10.26% quarter-over-quarter from $195.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Cash & Current Investments (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Cash & Current Investments history runs 6 years deep, the most recent figure standing at $175.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 53.08% year-over-year to $175.0 million; the TTM figure through Mar 2026 stood at $175.0 million (down 53.08% YoY), while the FY2025 annual figure was $195.0 million, down 39.06% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $175.0 million, down from $195.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $893.0 million in Q4 2022, with the low at $175.0 million in Q1 2026.
- The 5-year median for Cash & Current Investments is $391.5 million (2023), against an average of $415.1 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments dropped 18.97% in 2022, then sank 54.09% in 2023.
- Indivior Pharmaceuticals' Cash & Current Investments stood at $893.0 million in 2022, then tumbled by 54.09% to $410.0 million in 2023, then retreated by 21.95% to $320.0 million in 2024, then slumped by 39.06% to $195.0 million in 2025, then slipped by 10.26% to $175.0 million in 2026.
- Business Quant data shows INDV's Cash & Current Investments at $175.0 million in Q1 2026, $195.0 million in Q4 2025, and $445.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn | 222.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 222.00 Mn |
| Mar 31, 2026 | 175.00 Mn |
| Dec 31, 2025 | 195.00 Mn |
| Sep 30, 2025 | 445.00 Mn |
| Jun 30, 2025 | 510.00 Mn |
| Mar 31, 2025 | 373.00 Mn |
| Dec 31, 2024 | 320.00 Mn |
| Dec 31, 2023 | 410.00 Mn |
| Dec 31, 2022 | 893.00 Mn |
| Dec 31, 2021 | 1.10 Bn |